A modern, dynamically developing Russian pharmaceutical company, which is one of the leaders of the pharmaceutical industry of the Russian Federation.
The company’s turnover amounted to more than 36 billion rubles in 2022, with an increase of more than 250%.
Skopinpharm is a developer and manufacturer of medicines, one of the major suppliers under the high-cost nosology program and the largest supplier for the needs of the Circle of Good Foundation for Helping Children with Severe and Life-Threatening Diseases.
The company implements two Special investment contracts: for the production of drugs from blood plasma and for the treatment of oncological diseases. As part of the implementation of these two contracts, new production and warehouse buildings are being built, unique technologies for the production of medicines are being transferred, a plasma storage facility is being built to store plasma for fractionation (raw materials for the production of blood products). At the same time, a modern system for blood plasma procurement is being created in partnership with health authorities and a voluntary donation program is being developed.
The success of Skopinpharm was noted by the Russian Union of Industrialists and Entrepreneurs for «Dynamic business development» and «For the import substitution project».
The Skopinpharm plant is located in the Industrial Zone No. 1 of the Skopinsky district of the Ryazan region.